| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 18.552 | 18.542 | 15.752 | 15.160 | 18.221 | 20.879 | 42.281 | 42.667 | 26.385 | 29.344 |
| Total Income - EUR | 18.554 | 18.543 | 15.773 | 15.160 | 18.224 | 20.882 | 42.282 | 42.670 | 26.389 | 29.346 |
| Total Expenses - EUR | 12.441 | 16.781 | 14.124 | 16.268 | 15.043 | 19.101 | 26.514 | 19.607 | 28.127 | 22.965 |
| Gross Profit/Loss - EUR | 6.113 | 1.762 | 1.648 | -1.108 | 3.181 | 1.780 | 15.769 | 23.063 | -1.738 | 6.382 |
| Net Profit/Loss - EUR | 5.560 | 1.308 | 1.189 | -1.563 | 2.634 | 1.154 | 14.855 | 21.932 | -1.993 | 6.094 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Silvet Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.548 | 2.522 | 2.480 | 2.434 | 2.387 | 2.342 | 2.290 | 2.297 | 2.294 | 2.281 |
| Current Assets | 2.296 | 4.460 | 4.559 | 3.636 | 8.712 | 10.817 | 28.608 | 45.528 | 8.949 | 8.882 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 450 | 0 | 0 |
| Receivables | 1.008 | 54 | 1.075 | 602 | 643 | 0 | 0 | 223 | 2.293 | 4.237 |
| Cash | 1.288 | 4.407 | 3.484 | 3.034 | 8.069 | 10.817 | 28.608 | 44.854 | 6.656 | 4.645 |
| Shareholders Funds | 3.709 | 4.979 | 6.084 | 4.409 | 6.958 | 7.980 | 22.658 | 38.504 | -1.944 | 4.161 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.135 | 2.003 | 954 | 1.661 | 4.141 | 5.179 | 8.240 | 9.321 | 13.241 | 7.003 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Silvet Med Srl